【心衰竭】《HAYA Therapeutics》完成6,500萬美元A輪，將用於心衰竭藥物臨床開發

 【心臟衰竭】《HAYA Therapeutics》完成6,500萬美元A輪，將用於心臟衰竭候選藥物的臨床開發

 文章出處  

Businesswire 

 

 原文標題  

HAYA Therapeutics Raises $65 Million in Series A Funding to Deliver Precision RNA-Guided Medicines for Chronic and Age-Related Diseases 

 

 Twitter  

https://x.com/aimedadviser/status/1921082985555624204 

 

 文章序號  

7935 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2025 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.